Drug Repositioning in Friedreich Ataxia.
drug development
drug repositioning
frataxin
friedreich ataxia
therapeutics
Journal
Frontiers in neuroscience
ISSN: 1662-4548
Titre abrégé: Front Neurosci
Pays: Switzerland
ID NLM: 101478481
Informations de publication
Date de publication:
2022
2022
Historique:
received:
13
11
2021
accepted:
07
01
2022
entrez:
28
2
2022
pubmed:
1
3
2022
medline:
1
3
2022
Statut:
epublish
Résumé
Friedreich ataxia is a rare neurodegenerative disorder caused by insufficient levels of the essential mitochondrial protein frataxin. It is a severely debilitating disease that significantly impacts the quality of life of affected patients and reduces their life expectancy, however, an adequate cure is not yet available for patients. Frataxin function, although not thoroughly elucidated, is associated with assembly of iron-sulfur cluster and iron metabolism, therefore insufficient frataxin levels lead to reduced activity of many mitochondrial enzymes involved in the electron transport chain, impaired mitochondrial metabolism, reduced ATP production and inefficient anti-oxidant response. As a consequence, neurons progressively die and patients progressively lose their ability to coordinate movement and perform daily activities. Therapeutic strategies aim at restoring sufficient frataxin levels or at correcting some of the downstream consequences of frataxin deficiency. However, the classical pathways of drug discovery are challenging, require a significant amount of resources and time to reach the final approval, and present a high failure rate. Drug repositioning represents a viable alternative to boost the identification of a therapy, particularly for rare diseases where resources are often limited. In this review we will describe recent efforts aimed at the identification of a therapy for Friedreich ataxia through drug repositioning, and discuss the limitation of such strategies.
Identifiants
pubmed: 35221903
doi: 10.3389/fnins.2022.814445
pmc: PMC8863941
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
814445Informations de copyright
Copyright © 2022 Rufini, Malisan, Condò and Testi.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Nat Commun. 2016 Feb 04;7:10606
pubmed: 26842135
Hum Mol Genet. 2012 Jul 1;21(13):2855-61
pubmed: 22447512
Hum Mol Genet. 2013 Jul 1;22(13):2662-75
pubmed: 23474817
Lancet Neurol. 2021 May;20(5):330-332
pubmed: 33770529
Biochemistry (Mosc). 2019 Aug;84(8):829-850
pubmed: 31522667
Nat Chem Biol. 2006 Oct;2(10):551-8
pubmed: 16921367
Am J Hum Genet. 1996 Sep;59(3):554-60
pubmed: 8751856
Int J Mol Sci. 2014 Apr 04;15(4):5789-806
pubmed: 24714088
Blood. 2008 Aug 15;112(4):1005-12
pubmed: 18477770
Mov Disord. 2011 Mar;26(4):739-42
pubmed: 21506154
J Neurol Sci. 2011 Aug 15;307(1-2):46-9
pubmed: 21652007
Proc Natl Acad Sci U S A. 2002 Feb 19;99(4):2258-63
pubmed: 11854521
Int J Mol Sci. 2017 Oct 18;18(10):
pubmed: 29057804
Ann Neurol. 2017 Feb;81(2):212-226
pubmed: 28009062
Oxid Med Cell Longev. 2013;2013:487534
pubmed: 23936609
Int J Lab Hematol. 2016 May;38 Suppl 1:20-6
pubmed: 27161430
Elife. 2017 Dec 19;6:
pubmed: 29257745
J Biol Chem. 2006 Feb 10;281(6):3261-7
pubmed: 16344552
Biomedicines. 2018 Sep 09;6(3):
pubmed: 30205595
Front Pharmacol. 2014 Jun 03;5:130
pubmed: 24917819
Hum Mol Genet. 1997 Oct;6(11):1771-80
pubmed: 9302253
Arch Toxicol. 2014 Oct;88(10):1773-86
pubmed: 25164826
Nat Commun. 2019 May 17;10(1):2210
pubmed: 31101807
Sci Rep. 2019 Oct 10;9(1):14568
pubmed: 31601825
Neurobiol Dis. 2015 Mar;75:91-9
pubmed: 25549872
Eur J Clin Pharmacol. 2005 May;61(3):189-95
pubmed: 15776276
Cerebellum. 2006;5(1):55-63
pubmed: 16527765
J Neural Transm (Vienna). 2005 Jun;112(6):789-96
pubmed: 15480852
Lancet. 2014 Aug 9;384(9942):504-13
pubmed: 24794816
Muscle Nerve. 2019 Nov;60(5):571-575
pubmed: 31206761
Acta Neurol Scand. 2015 Jul;132(1):7-15
pubmed: 25335475
Mol Cell. 2005 Mar 18;17(6):855-68
pubmed: 15780941
Lancet Neurol. 2015 Feb;14(2):174-82
pubmed: 25566998
Diabetes Spectr. 2017 Aug;30(3):202-210
pubmed: 28848315
Sci Transl Med. 2021 Jun 2;13(596):
pubmed: 34078742
Hum Mol Genet. 2015 Aug 1;24(15):4296-305
pubmed: 25948553
Physiol Rev. 1992 Apr;72(2):449-89
pubmed: 1557429
Int J Mol Sci. 2019 Oct 21;20(20):
pubmed: 31640150
Sci Rep. 2018 Nov 19;8(1):17043
pubmed: 30451920
Eur J Clin Invest. 2005 Nov;35(11):711-7
pubmed: 16269021
Chem Biol. 2009 Sep 25;16(9):980-9
pubmed: 19778726
JAMA Intern Med. 2018 Apr 1;178(4):587
pubmed: 29610869
Neurol Res Pract. 2019 Oct 15;1:33
pubmed: 33324899
Cell Death Dis. 2011 Feb 24;2:e123
pubmed: 21368894
Mov Disord. 2016 May;31(5):734-41
pubmed: 26879839
JCI Insight. 2020 Jan 30;5(2):
pubmed: 31877117
J Antimicrob Chemother. 2020 Dec 1;75(12):3699-3700
pubmed: 32954404
Hum Mol Genet. 2007 Jul 1;16(13):1534-40
pubmed: 17468497
Neurochem Int. 2011 Feb;58(3):248-60
pubmed: 21130821
PLoS One. 2009;4(1):e4253
pubmed: 19158945
Cell. 1999 Jul 9;98(1):115-24
pubmed: 10412986
Clin Pharmacokinet. 2020 Feb;59(2):137-154
pubmed: 31679131
Int J Mol Sci. 2015 Jun 17;16(6):13885-907
pubmed: 26090715
Expert Rev Anticancer Ther. 2014 Jul;14(7):765-70
pubmed: 24875651
Expert Opin Pharmacother. 2019 Oct;20(15):1855-1867
pubmed: 31311349
Front Neurosci. 2020 Oct 09;14:872
pubmed: 33162876
J Biol Chem. 2006 Jun 16;281(24):16750-6
pubmed: 16608849
Ann Neurol. 1997 May;41(5):675-82
pubmed: 9153531
Hum Mol Genet. 2009 Jul 1;18(13):2452-61
pubmed: 19376812
Ann N Y Acad Sci. 2020 Feb;1461(1):104-126
pubmed: 31392745
PLoS One. 2020 Dec 8;15(12):e0240949
pubmed: 33290416
Hum Mol Genet. 2017 Aug 1;26(15):2864-2873
pubmed: 28460056
Drugs. 2012 Apr 16;72(6):847-69
pubmed: 22512366
J Neuropathol Exp Neurol. 2012 Aug;71(8):708-15
pubmed: 22805773
Hum Mol Genet. 2015 May 1;24(9):2615-26
pubmed: 25628335
Molecules. 2020 Oct 12;25(20):
pubmed: 33053864
Neurobiol Dis. 2019 Dec;132:104606
pubmed: 31494282
Hum Mol Genet. 2015 Apr 15;24(8):2274-86
pubmed: 25552656
Hum Mol Genet. 2020 Feb 1;29(3):471-482
pubmed: 31943004
Nat Rev Drug Discov. 2019 Jan;18(1):41-58
pubmed: 30310233
PLoS Genet. 2010 Jan 15;6(1):e1000812
pubmed: 20090835
Pharmacol Res. 2021 Jan;163:105283
pubmed: 33160067
J Food Biochem. 2021 Aug 5;:e13886
pubmed: 34350614
Ann Clin Transl Neurol. 2019 Feb 27;6(3):546-553
pubmed: 30911578
Mol Ther. 2018 Aug 1;26(8):1940-1952
pubmed: 29853274
Front Pharmacol. 2014 Jul 16;5:152
pubmed: 25076907
Neurobiol Dis. 2021 Jan;148:105162
pubmed: 33171227
J Neurochem. 2011 Jul;118(2):288-303
pubmed: 21554323
Neurology. 1984 Nov;34(11):1493-7
pubmed: 6493499
Mov Disord. 2008 Oct 15;23(13):1940-4
pubmed: 18759345
Mov Disord. 2011 Aug 15;26(10):1935-8
pubmed: 21692115
Circ Res. 2010 Jun 11;106(11):1722-30
pubmed: 20395592
J Neuropathol Exp Neurol. 2013 Feb;72(2):78-90
pubmed: 23334592
Antioxidants (Basel). 2020 Jun 13;9(6):
pubmed: 32545803
Bioorg Med Chem. 2020 Jun 1;28(11):115472
pubmed: 32279920
Cell Rep. 2017 Feb 21;18(8):2007-2017
pubmed: 28228265
Lancet Neurol. 2021 May;20(5):362-372
pubmed: 33770527
Mol Neurodegener. 2012 Oct 05;7:51
pubmed: 23039828
Free Radic Biol Med. 2016 Jun;95:16-26
pubmed: 26968794
Expert Opin Orphan Drugs. 2016;4(9):961-970
pubmed: 28392990
Proc Natl Acad Sci U S A. 1998 Apr 14;95(8):4635-40
pubmed: 9539790
AMA Arch Derm. 1955 Jun;71(6):728-30
pubmed: 14375392
Hum Mol Genet. 2010 Apr 1;19(7):1221-9
pubmed: 20053667
J Exp Med. 1997 Dec 15;186(12):2023-31
pubmed: 9396771
Curr Med Chem. 2021;28(11):2085-2099
pubmed: 32867630
Biochem Biophys Res Commun. 2014 Jun 6;448(3):335-41
pubmed: 24735535
Ann Neurol. 2012 Dec;72(6):971-82
pubmed: 23280845
Mov Disord. 2019 Mar;34(3):323-334
pubmed: 30624801
Am J Hum Genet. 2018 Feb 1;102(2):266-277
pubmed: 29395073
PLoS One. 2019 Jun 3;14(6):e0217776
pubmed: 31158268
Nat Med. 2014 May;20(5):542-7
pubmed: 24705334
Ann Neurol. 2016 Mar;79(3):485-95
pubmed: 26704351
Cerebellum. 2011 Dec;10(4):763-9
pubmed: 21597884
Clin Cancer Res. 2006 Apr 15;12(8):2607-12
pubmed: 16638873
Mol Aspects Med. 2020 Oct;75:100864
pubmed: 32461004
Eur J Clin Invest. 2010 Jun;40(6):561-5
pubmed: 20456483
Neurotherapeutics. 2019 Oct;16(4):1032-1049
pubmed: 31317428
Proteomes. 2016 Sep 12;4(3):
pubmed: 28248238
Hum Mol Genet. 2012 Mar 15;21(6):1230-47
pubmed: 22113996
Sci Total Environ. 2020 Mar 10;707:135624
pubmed: 31784171
J Biol Chem. 1990 Sep 25;265(27):16644-55
pubmed: 2398066
Neurosci Lett. 2011 Jan 7;487(2):153-7
pubmed: 20951187
Dis Model Mech. 2015 Mar;8(3):225-35
pubmed: 25681319
BMJ Case Rep. 2013 May 22;2013:
pubmed: 23704441
Front Neurosci. 2019 Apr 24;13:386
pubmed: 31105516
PLoS One. 2012;7(8):e42703
pubmed: 22900042
Front Cell Neurosci. 2018 Jul 17;12:188
pubmed: 30065630
Ann Neurol. 2014 Oct;76(4):522-8
pubmed: 25112975
Neurol Sci. 2016 Mar;37(3):361-4
pubmed: 26621361
Blood. 2021 Apr 15;137(15):2090-2102
pubmed: 33529321
Neurodegener Dis Manag. 2018 Aug;8(4):233-242
pubmed: 30051753
FEBS Open Bio. 2018 Jan 25;8(3):390-405
pubmed: 29511616
Dis Model Mech. 2017 Nov 1;10(11):1343-1352
pubmed: 29125827
Mov Disord. 2018 Jul;33(6):1000-1005
pubmed: 29624723
Ill Dent J. 1992 Jul-Aug;61(4):303-4
pubmed: 1286862
Neuropharmacology. 2017 Sep 1;123:34-45
pubmed: 28504123
Oncol Lett. 2021 Nov;22(5):750
pubmed: 34539854
Expert Opin Drug Discov. 2020 Apr;15(4):397-401
pubmed: 31847616
Brief Bioinform. 2011 Jul;12(4):346-56
pubmed: 21504985
Antioxid Redox Signal. 2016 Jul 10;25(2):61-77
pubmed: 27009601
Ann Pharmacother. 2013 Dec;47(12):1697-702
pubmed: 24259625
Biol Open. 2016 May 15;5(5):654-61
pubmed: 27106929
Nutrients. 2020 May 31;12(6):
pubmed: 32486488
Cell Metab. 2012 Jun 6;15(6):838-47
pubmed: 22682224
Cerebellum. 2008;7(3):360-5
pubmed: 18581197
Science. 2004 Jul 9;305(5681):239-42
pubmed: 15247477
Acta Pharm Sin B. 2020 Jun;10(6):961-978
pubmed: 32642405
Mov Disord. 1996 Jul;11(4):437-9
pubmed: 8813226
Proc Natl Acad Sci U S A. 2000 Sep 12;97(19):10526-31
pubmed: 10984541
J Pharmacol Exp Ther. 2009 Dec;331(3):827-35
pubmed: 19741150
Nutrients. 2020 May 12;12(5):
pubmed: 32408706
Nucleic Acids Res. 2019 Nov 18;47(20):10728-10743
pubmed: 31584077
BMC Neurol. 2016 Jan 12;16:3
pubmed: 26755195
Mov Disord. 2012 Mar;27(3):446-9
pubmed: 22411849
Can J Neurol Sci. 1976 Nov;3(4):379-88
pubmed: 1000425
J Child Neurol. 2012 Sep;27(9):1133-7
pubmed: 22752493
Br Med J. 1962 Jul 21;2(5298):159-61
pubmed: 14450233
Brain. 2011 Mar;134(Pt 3):678-92
pubmed: 21354971
Int J Obes (Lond). 2015 Nov;39(11):1651-4
pubmed: 26228460
Int J Obes Relat Metab Disord. 2003 Mar;27(3):313-8
pubmed: 12629557
Cancer Chemother Pharmacol. 1994;34(5):399-404
pubmed: 8070006
Mov Disord. 2014 Jun;29(7):935-9
pubmed: 24515352
Hum Mol Genet. 2018 Sep 1;27(17):2965-2977
pubmed: 29790959
Ann Neurol. 2007 Nov;62(5):521-4
pubmed: 17702040
J Neurol. 2015 May;262(5):1344-53
pubmed: 25845763
Int J Mol Sci. 2013 Apr 10;14(4):7853-65
pubmed: 23574943
Expert Rev Neurother. 2020 Dec;20(12):1215-1228
pubmed: 32909841
Blood. 2008 Feb 15;111(4):1767-72
pubmed: 18057230
Neuroreport. 2021 Aug 11;32(12):1041-1048
pubmed: 34232130
PLoS One. 2013;8(2):e55940
pubmed: 23418481
Hum Mol Genet. 2011 Apr 1;20(7):1253-61
pubmed: 21216878
J Cancer Res Clin Oncol. 2013 Dec;139(12):1971-84
pubmed: 23942795
Lancet. 2007 Jul 7;370(9581):39-48
pubmed: 17617271
Nat Genet. 1997 Oct;17(2):215-7
pubmed: 9326946
Can J Neurol Sci. 2001 May;28(2):134-40
pubmed: 11383938
Nat Rev Immunol. 2018 Sep;18(9):545-558
pubmed: 29921905
Hum Mol Genet. 2007 Apr 15;16(8):929-41
pubmed: 17331979
J Antimicrob Chemother. 2013 May;68(5):1161-8
pubmed: 23335197
Front Physiol. 2012 Mar 13;3:50
pubmed: 22419911
J Neurochem. 2013 Aug;126 Suppl 1:94-102
pubmed: 23859345
Ann Hematol. 2003 Apr;82(4):207-13
pubmed: 12707722
J Neuropathol Exp Neurol. 2017 Feb 1;76(2):101-108
pubmed: 28082326
Mov Disord. 2020 Feb;35(2):370-371
pubmed: 31930551
Hum Mol Genet. 2021 Feb 25;29(24):3954-3965
pubmed: 33432356
Int J Cardiol. 2016 Oct 15;221:376-8
pubmed: 27404709
Hum Mol Genet. 2014 Dec 20;23(25):6848-62
pubmed: 25113747
Phytother Res. 2021 Oct;35(10):5440-5458
pubmed: 34184327
Nature. 2007 Nov 15;450(7168):440-4
pubmed: 18004385
Int J Biochem Cell Biol. 2013 Jan;45(1):90-8
pubmed: 22951354
PLoS One. 2010 Apr 07;5(4):e10025
pubmed: 20383327
Antioxid Redox Signal. 2013 Nov 1;19(13):1481-93
pubmed: 23350650
Cerebellum. 2009 Jun;8(2):98-103
pubmed: 19104905
J Neurol Neurosurg Psychiatry. 1992 Feb;55(2):136-7
pubmed: 1538220
JCI Insight. 2017 Jul 20;2(14):
pubmed: 28724806
Circ Res. 2008 Nov 21;103(11):1232-40
pubmed: 18845810
Hum Mol Genet. 2018 Mar 15;27(6):992-1001
pubmed: 29325032
J Med Chem. 2019 May 23;62(10):4851-4883
pubmed: 30516990
Curr Pharm Des. 2020;26(12):1277-1285
pubmed: 32048954
Neurodegener Dis Manag. 2021 Apr;11(2):91-98
pubmed: 33430645
Ann Clin Transl Neurol. 2016 Jul 25;3(9):684-94
pubmed: 27648458
Expert Opin Emerg Drugs. 2021 Dec;26(4):415-423
pubmed: 34693848
J Cell Mol Med. 2018 Feb;22(2):834-848
pubmed: 28980774
Science. 2017 Dec 22;358(6370):1617-1622
pubmed: 29192133